Thrombolytics in Stroke: Moving Beyond Controversy to Comprehensive Care
The use of thrombolytics for acute ischemic stroke may be one of the most controversial topics in…
Thrombolytics
-
Thrombolytics in Stroke: Moving Beyond Controversy to Comprehensive Care
The use of thrombolytics for acute ischemic stroke may be one of the most controversial topics in... -
The Latest Research in Neurologic Emergencies
You may have mastered all the latest changes affecting management of sepsis, STEMI, and opiate-use disorder, but... -
Genentech Docs Push Back on tPA No-Efficacy Article; Authors Respond
On Sept. 25, 2020, ACEP Now published Ken Milne’s article entitled “After Re-Analysis, No Trials Show Efficacy...
The Latest Research in Neurologic Emergencies
You may have mastered all the latest changes affecting management of sepsis, STEMI, and opiate-use disorder, but…
Genentech Docs Push Back on tPA No-Efficacy Article; Authors Respond
On Sept. 25, 2020, ACEP Now published Ken Milne’s article entitled “After Re-Analysis, No Trials Show Efficacy…
After Re-Analysis, No Trials Show Efficacy of tPA in Acute Ischemic Stroke
The Case A 71-year-old woman arrives to the ED by EMS with right-sided weakness beginning 3 hours…
In-hospital Strokes Evaluated, Treated More Slowly Than Those Occurring in the Community
Strokes that happen in the hospital aren’t evaluated and treated as quickly as strokes that happen in…
Recommendation to Update tPA Policy Approved by ACEP Board
In response to amended Resolution 32 from the 2013 Council meeting, the ACEP Board of Directors instructed…
Comment Period for tPA Clinical Policy Closing Soon
Comments related to guidelines about use of intravenous thrombolytics for ischemic stroke must be submitted to ACEP…